U.S. FDA Approves Bristol Myers Squibb’s COBENFY, a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults ...

Xanomeline and trospium chloride is a first-in-class medication that selectively targets the M1 and M4 receptors without blocking D2 receptors.

The FDA has approved Cobenfy, a dual M1/M4 muscarinic agonist that offers a fundamentally different approach to treating ...

CNBC's Angelica Peebles joins 'Fast Money' to report on Bristol Myers Squibb's stock rise following FDA approval of Cobenfy ...

The FDA has approved Bristol Myers Squibb’s new schizophrenia drug, Cobenfy, the first novel treatment for schizophrenia in ...

The FDA has approved Cobenfy capsules from Bristol-Myers Squibb for the oral treatment of schizophrenia in adults. The medication, formerly known as KarXT, is the first antipsychotic medication to ...

A medicine that sidesteps the brain's dopamine receptors to reach different targets represents a new approach to schizophrenia treatment. The Food and Drug Administration approved it Thursday.

On Thursday, the Food and Drug Administration approved Cobenfy, a drug from Bristol Myers Squibb—the first truly novel ...

British scientists have hailed the US approval of a new drug for schizophrenia, saying it “has the potential to change the ...

A Collier County jury has convicted a Fort Myers man of second-degree murder for a March 2021 deadly shooting at a North Naples restaurant. Jason Ortiz, 33, was charged in the March 12 ...

BRISTOL, Va. (WJHL) – The Bristol Virginia Police Criminal Investigations located a suspect vehicle from a shooting that occurred on Thursday, according to a release from the department.

BRISTOL, Conn. (WTNH) — A parent of a Bristol student was arrested on Wednesday after making a concerning post on social media. Bristol police investigating shots fired at park David Arroyo, Jr ...